Solar Biotech, Inc. Receives Investment from Ingredion Inc. to Accelerate the Development of its Advanced SynBio Bioprocessing Technologies and Proprietary SynBio Products Pipeline
yahoo.com
news
2022-06-01 14:17:00

Key Takeaway : investment will expand Solar Biotech's unique end-to-end bioprocessing capabilities and proprietary platform to manufacture high-value products used in multiple SynBio market segments, including the fast-growing FoodTech industry.

NORTON, Va., June 1, 2022 /PRNewswire/ -- Solar Biotech Incorporated announced today an investment by Ingredion Incorporated (NYSE: INGR) in Solar Biotech, a growing leader in advanced SynBio bioprocessing technologies and proprietary products. Terms of the investment were not disclosed.
